Ainos (STU:FZX0) Quality Rank


STU:FZX0 Ainos Inc STU:FZX0
24 GF Score
Price €12.50
GF Value €0.91
! 9 Warning Signs
View Full Analysis

What is Ainos Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Ainos Quality Rank Related Terms

STU:FZX0
24GF Score
Ainos Inc STU:FZX0
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ainos (STU:FZX0) Overvalued in 2026?

Based on GuruFocus' analysis, Ainos stock appears to be overvalued. The current stock price of €12.50 is trading 1273.6% above its estimated GF Value™ of €0.91.

Key valuation signals for STU:FZX0:

  • Quality Rank:
  • GF Value™: €0.91 vs. price of €12.50 (1273.6% above fair value)
  • GF Score™: 24/100 with 9 warning signs

No single metric tells the full story. See the STU:FZX0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ainos Business Description

Other Exchanges AIMD:USA
Address 3050 Post Oak Boulevard, Suite 510-T80, Houston, TX, USA, 77056
Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.
24GF Score

Get the complete analysis for STU:FZX0

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.50
Price
€0.91
GF Value